Placebo SC Injection

DRUG3 trials

Sponsors

Pfizer, Sarepta Therapeutics, Inc., Absci Pty Ltd.

Conditions

Androgenetic Alopecia (AGA)HealthyHealthy Volunteers - Male and FemaleMyotonic Dystrophy 1

Phase 1

Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People

TerminatedNCT01162889

Start: 2010-06-30End: 2012-01-31Updated: 2012-03-15

Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy

RecruitingNCT06138743

Sarepta Therapeutics, Inc.Myotonic Dystrophy 1

Start: 2024-03-04End: 2026-12-31Target: 78Updated: 2026-08-11

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia

RecruitingNCT07317544

Absci Pty Ltd.Androgenetic Alopecia (AGA), Healthy Volunteers - Male and Female

Start: 2025-12-03End: 2028-07-01Target: 227Updated: 2026-09-03